XBI

How is XBI doing right now?

In plain terms: XBI is 21.8% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

XBI (SPDR S&P Biotech ETF) is 21.8% below its historical peak. Tape reads in a deep drawdown, with the last trade at $135.34. Deep drawdowns shift the conversation from "is this a buy" to "what's broken". Sometimes it's macro. Sometimes it's the asset itself. Dipsern's data tells you which one history rewarded.

What history says at this drawdown

Across all available history, XBI has spent enough trading days in the 25%-to-20% drawdown band to build a large sample (499 observations). Dipsern segments these by drawdown depth and computes the rolling median forward 90-day return — that median is the primary signal you see in the full app, and it's substantially more robust than mean-based forecasts because it ignores fat-tail outliers in both directions.

What this means for XBI

For broad-index ETFs the historical base rate is exceptionally stable; for narrow thematic ETFs (e.g., ARKK, cannabis, leveraged), drawdowns are deeper and the sample size at each band is smaller. Deep drawdowns require a story for why this time isn't different. The Dipsern signal can tell you what historically happened next; it can't tell you whether the current setup matches the historical analog.